|
U.S. Patent No. 7,704,985:
|
Treatment of irritable bowel syndrome and related bowel diseases |
|
U.S. Patent No. 7,702,430: |
Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase |
|
U.S. Patent No. 7,700,731: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 7,696,150: |
Modulation of the activity of an interleukin 17 receptor-related protein, EVI27, and uses thereof |
|
U.S. Patent No. 7,685,577: |
System and method for translating an asset for distribution over multi-tiered networks |
|
U.S. Patent No. 7,685,183: |
System and method for synchronizing assets |
|
U.S. Patent No. 7,674,464: |
Intracellular interleukin-1 receptor antagonists |
|
U.S. Patent No. 7,668,659: |
Diagnosis and classification of multiple myeloma |
|
U.S. Patent No. 7,667,026: |
Population scale HLA-typing and uses thereof |
|
U.S. Patent No. 7,659,306: |
Method of increasing gastric
emptying |
|
U.S. Patent No. 7,659,062: |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
|
U.S. Patent No. 7,647,099: |
Controlled release transdermal drug delivery |
|
U.S. Patent No. 7,642,238: |
Molecular determinants of myeloma bone disease and uses thereof |
|
U.S. Patent No. 7,638,277: |
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
|
|
U.S. Patent No. 7,625,554: |
Treatment of alzheimer's disease
|
|
U.S. Patent No. 7,588,565: |
Method and device for anastomoses |
|
U.S. Patent No. 7,582,620: |
Use of mannan from saccharomyces cerevisiae |
|
U.S. Patent No. 7,547,545: |
Directed in vitro differentiation of marrow |
|
U.S. Patent No. 7,544,780: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 7,541,156: |
Method of identifying antinociceptive compounds |
|
U.S. Patent No. 7,539,579: |
Oligonucleotide probes for genosensor chips |
|
U.S. Patent No. 7,704,985: |
Treatment of irritable bowel syndrome and related bowel diseases |
|
U.S. Patent No. 7,702,430: |
Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase |
|
U.S. Patent No. 7,700,731: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 7,696,150: |
Modulation of the activity of an interleukin 17 receptor-related protein, EVI27, and uses thereof |
|
U.S. Patent No. 7,685,577: |
System and method for translating an asset for distribution over multi-tiered networks |
|
U.S. Patent No. 7,685,183: |
System and method for synchronizing assets on multi-tiered networks |
|
U.S. Patent No. 7,674,464: |
Intracellular interleukin-1 receptor antagonists |
|
U.S. Patent No. 7,668,659: |
Diagnosis and classification of multiple myeloma |
|
U.S. Patent No. 7,667,026: |
Population scale HLA-typing and uses thereof |
|
U.S. Patent No. 7,659,306: |
Method of increasing gastric emptying |
|
U.S. Patent No. 7,659,062: |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors |
|
U.S. Patent No. 7,647,099: |
Controlled release transdermal drug delivery |
|
U.S. Patent No. 7,642,238: |
Molecular determinants of myeloma bone disease and uses thereof |
|
U.S. Patent No. 7,638,277: |
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
|
U.S. Patent No. 7,625,554: |
Treatment of alzheimer's disease |
|
U.S. Patent No. 7,588,565: |
Method and device for anastomoses |
|
U.S. Patent No. 7,582,620: |
Use of mannan from saccharomyces cerevisiae for the treatment of asthma |
|
U.S. Patent No. 7,547,545: |
Directed in vitro differentiation of marrow stromal cells into neural cell progenitors |
|
U.S. Patent No. 7,544,780: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 7,541,156: |
Method of identifying antinociceptive compounds using protease activated receptor-2 |
|
U.S. Patent No. 7,539,579: |
Oligonucleotide probes for genosensor chips |
|
U.S. Patent No. 7,537,901: |
Extracellular serine protease |
|
U.S. Patent No. 7,524,663: |
Covalently reactive transition state analogs and methods of use thereof |
|
U.S. Patent No. 7,521,534: |
IKK gamma gene products and methods for making and using same |
|
U.S. Patent No. 7,514,531: |
Specific binding sites in collagen for integrins and use thereof |
|
U.S. Patent No. 7,501,249: |
Human cytoplasmic polyadenylation element binding protein and uses thereof |
|
U.S. Patent No. 7,500,953: |
High contrast optoacoustic imaging using nanoparticles |
|
U.S. Patent No. 7,483,736: |
Feedback control device for transcutaneous drug delivery and uses therefor |
|
U.S. Patent No. 7,482,323: |
Intracellular interleukin-1 receptor antagonist and uses thereof |
|
U.S. Patent No. 7,476,551: |
Diagnosing atherosclerosis risk by measuring carbamylated low density lipoprotein levels |
|
U.S. Patent No. 7,459,437: |
Molecular determinants of myeloma bone disease and uses thereof |
|
U.S. Patent No. 7,438,933: |
Maternal multi-nutrient against diabetes-related birth defects |
|
U.S. Patent No. 7,430,610: |
System and method for adjusting the distribution of an asset over a multi-tiered network |
|
U.S. Patent No. 7,419,996: |
Parenteral and oral formulations of benzimidazoles |
|
U.S. Patent No. 7,390,462: |
Ratiometric fluorescent pH sensor for non-invasive monitoring |
|
U.S. Patent No. 7,380,942: |
Method for measuring the wave aberrations of the eye |
|
U.S. Patent No. 7,371,736: |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss |
|
U.S. Patent No. 7,370,964: |
Measuring refractive characteristics of human eyes |
|
U.S. Patent No. 7,368,232: |
High-throughput assay for virus entry and drug screening |
|
U.S. Patent No. 7,354,710: |
Methods and devices based upon a novel form of nucleic acid duplex on a surface |
|
U.S. Patent No. 7,348,145: |
Clinical assays for the detection and typing of human herpesviruses |
|
U.S. Patent No. 7,335,351: |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
|
U.S. Patent No. 7,332,322: |
Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof |
|
U.S. Patent No. 7,329,486: |
High-throughput assay for virus entry and drug screening |
|
U.S. Patent No. 7,311,400: |
Determining clinical refraction of eye |
|
U.S. Patent No. 7,308,364: |
Diagnosis of multiple myeloma on gene expression profiling |
|
U.S. Patent No. 7,306,927: |
Method of inducing immunity against stratum corneum chymotrytic enzyme |
|
U.S. Patent No. 7,304,137: |
Nucleotide and amino acid sequences of asporins |
|
U.S. Patent No. 7,303,281: |
Method and device for determining refractive components and visual function of the eye for vision correction |
|
U.S. Patent No. 7,291,462: |
TADG-15: an extracellular serine protease overexpressed in carcinomas |
|
U.S. Patent No. 7,282,198: |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
|
U.S. Patent No. 7,265,216: |
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
|
U.S. Patent No. 7,256,886: |
Surface enhanced Raman spectroscopic nano-imaging probe and uses therefor |
|
U.S. Patent No. 7,253,293: |
Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof |
|
U.S. Patent No. 7,242,470: |
Multilayered surface-enhanced Raman scattering substrates |
|
U.S. Patent No. 7,238,783: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 7,209,921: |
Method and system for deploying an asset over a multi-tiered network |
|
U.S. Patent No. 7,202,348: |
Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
|
U.S. Patent No. 7,182,933: |
Targeting drug/gene carriers to irradiated tissue |
|
U.S. Patent No. 7,181,731: |
Method, system, and structure for distributing and executing software and data on different network and computer devices, platforms, and environments |
|
U.S. Patent No. 7,169,396: |
Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1 |
|
U.S. Patent No. 7,157,098: |
Gene therapy of tumors using non-viral delivery system |
|
U.S. Patent No. 7,157,084: |
Extracellular serine protease |
|
U.S. Patent No. 7,136,857: |
Server system and method for distributing and scheduling modules to be executed on different tiers of a network |
|
U.S. Patent No. 7,125,673: |
CpG retrieval of DNA from formalin-fixed pathology specimen for promoter methylation analysis |
|
U.S. Patent No. 7,097,992: |
Uses of human UDP-glucuronosyltransferase 2B7 to detect and treat cancer |
|
U.S. Patent No. 7,094,886: |
Evi27 gene sequences and protein encoded thereby |
|
U.S. Patent No. 7,094,880: |
Decorin proteoglycan inhibitor of fibrinogen blood clotting |
|
U.S. Patent No. 7,083,790: |
Extracellular serine protease |
|
U.S. Patent No. 7,071,161: |
Variants of corticotropin releasing hormone receptor Type 1 and uses thereof |
|
U.S. Patent No. 7,067,630: |
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
|
U.S. Patent No. 7,067,250: |
Extracellular serine protease |
|
U.S. Patent No. 7,060,796: |
Antibody directed against purified .beta. 1,2-xylosyltransferase |
|
U.S. Patent No. 7,048,919: |
Osteoclast secreted chemokine and uses thereof |
|
U.S. Patent No. 7,045,127: |
Human anti-epidermal growth factor receptor single-chain antibodies |
|
U.S. Patent No. 7,041,869: |
Transgenic luciferase mouse |
|
U.S. Patent No. 7,037,686: |
Human cytoplasmic polyadenylation element binding protein and uses thereof |
|
U.S. Patent No. 7,034,020: |
Derivatives of butyric acid and uses thereof |
|
U.S. Patent No. 7,033,761: |
Expression miniarrays and uses thereof |
|
U.S. Patent No. 7,030,224: |
Human cytoplasmic polyadenylation element binding protein and uses thereof |
|
U.S. Patent No. 7,020,516: |
Catheter for delivering electromagnetic energy for enhanced permeation of substances |
|
U.S. Patent No. 7,018,834: |
Mutated herpes simplex virus type 1 thymidine kinases and uses thereof |
|
U.S. Patent No. 7,018,816: |
Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism |
|
U.S. Patent No. 7,014,993: |
Extracellular serine protease |
|
U.S. Patent No. 7,011,835: |
Targeted destruction of pests |
|
U.S. Patent No. 6,978,788: |
Minimally invasive treatment for breast cancer |
|
U.S. Patent No. 6,967,078: |
Interaction of Smad6 with Hox proteins and uses thereof |
|
U.S. Patent No. 6,967,076: |
Method for producing recombinant cells for detecting HIV |
|
U.S. Patent No. 6,964,762: |
Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
|
U.S. Patent No. 6,953,839: |
Prokaryotic collagen-like proteins and uses thereof |
|
U.S. Patent No. 6,943,015: |
Large scale production of packaged alphavirus replicons |
|
U.S. Patent No. 6,942,978: |
Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
|
U.S. Patent No. 6,924,146: |
Method of constructing vectors for homologous recombination directed mutagenesis |
|
U.S. Patent No. 6,913,756: |
Monoclonal antibodies specific for anthrax and peptides derived from the antibodies thereof |
|
U.S. Patent No. 6,900,010: |
Compositions and methods for detecting human immunodeficiency virus |
|
U.S. Patent No. 6,900,009: |
Method for creating a frozen tissue array |
|
U.S. Patent No. 6,897,301: |
Reference clones and sequences for non-subtype B isolates of human immunodeficiency virus type 1 |
|
U.S. Patent No. 6,897,062: |
DNA encoding the prostate-specific membrane antigen-like gene and uses thereof |
|
U.S. Patent No. 6,896,929: |
Susceptor shaft vacuum pumping |
|
U.S. Patent No. 6,890,954: |
Uses of 2-bromopalmitate in the treatment of autoimmune disease |
|
U.S. Patent No. 6,889,075: |
Optical imaging of subsurface anatomical structures and biomolecules |
|
U.S. Patent No. 6,887,887: |
Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
|
U.S. Patent No. 6,884,576: |
Methods of monitoring HIV drug resistance |
|
U.S. Patent No. 6,875,609: |
Methods for the early diagnosis of ovarian cancer |
|
U.S. Patent No. 6,872,404: |
Ophthalmologic uses of protein C |
|
U.S. Patent No. 6,870,027: |
Methods for the early diagnosis of ovarian cancer |
|
U.S. Patent No. 6,869,780: |
Nodavirus-like DNA expression vector and uses therefor |
|
U.S. Patent No. 6,846,488: |
Chimeric antigen-enterotoxin mucosal immunogens |
|
U.S. Patent No. 6,844,167: |
Pharmacological targeting of mRNA cap formation for treatment of parasitic infections |
|
U.S. Patent No. 6,827,987: |
Method of reducing an electrostatic charge on a substrate during a PECVD process |
|
U.S. Patent No. 6,824,971: |
Methods of inhibiting or enhancing the TGF.beta.-SMAD signaling pathway |
|
U.S. Patent No. 6,812,210: |
Urocortin-III and uses thereof |
|
U.S. Patent No. 6,803,231: |
Method of delivering antigens for vaccination with a live vector |
|
U.S. Patent No. 6,802,857: |
MRI stent |
|
U.S. Patent No. 6,800,610: |
Osteoclast secreted chemokine and uses thereof |
|
U.S. Patent No. 6,790,646: |
Mutants of monoamine oxidase B |
|
U.S. Patent No. 6,787,354: |
Methods for the early diagnosis of ovarian cancer |
|
U.S. Patent No. 6,787,341: |
Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections |
|
U.S. Patent No. 6,784,163: |
Inhibition of cationic amino acid transporter protein and uses thereof |
|
U.S. Patent No. 6,780,636: |
Cryoarray system and uses thereof |
|
U.S. Patent No. 6,777,220: |
Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
|
U.S. Patent No. 6,770,672: |
Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
|
|
|